U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
105121105121Efficacy of Exercise for Sexual Side Effects of AntidepressantsCompletedNo Results AvailableSexual DysfunctionBehavioral: Exercisehttps://ClinicalTrials.gov/show/NCT01189825
105122105122Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder SymptomsCompletedHas ResultsMajor Depressive Disorder|Dysthymia|Depression Not Otherwise Specified|Borderline Personality DisorderDrug: Lithium Carbonate|Drug: Placebo|Drug: Citalopramhttps://ClinicalTrials.gov/show/NCT01189812
105123105123Motivational Therapy for Substance Users With DepressionRecruitingNo Results AvailableDepression|Substance DependenceBehavioral: Motivational therapy|Other: Dual Recovery Anonymous/Treatment as usualhttps://ClinicalTrials.gov/show/NCT01189799
105124105124Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-SelectionRecruitingNo Results AvailableStem Cell Transplant|AllogeneicDevice: CliniMACS CD34 Reagent systemhttps://ClinicalTrials.gov/show/NCT01189786
105125105125Combined Analgesia to Control Pain in Children Seen in Emergency Department (ED) for a Trauma of a LimbCompletedNo Results AvailableTraumaDrug: ibuprofen and codeinehttps://ClinicalTrials.gov/show/NCT01189773
105126105126Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown LinesCompletedHas ResultsFacial Rhytides|Crow's Feet Lines|Glabellar LinesBiological: onabotulinumtoxinA 24 U|Biological: onabotulinumtoxinA 44 U|Drug: normal salinehttps://ClinicalTrials.gov/show/NCT01189760
105127105127Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet LinesCompletedHas ResultsLateral Canthus Rhytides|Crow's Feet LinesBiological: onabotulinumtoxinA|Drug: normal salinehttps://ClinicalTrials.gov/show/NCT01189747
105128105128Comparison Between Laparoscopic Common Bile Duct Exploration and Intraoperative ERCP for Management of Common Bile Duct StonesCompletedNo Results AvailableCommon Bile Duct GallstonesProcedure: laparoscopic common bile duct exploration|Procedure: laparoscopic cholecystectomy and intraoperative endoscopic sphincterotomyhttps://ClinicalTrials.gov/show/NCT01189734
105129105129Effect of Propofol on Remifentanil-induced Postoperative Hyperalgesia in Patients Undergoing Thyroid SurgeryRecruitingNo Results AvailableHyperalgesiaDrug: propofol, sevofluranehttps://ClinicalTrials.gov/show/NCT01189721
105130105130Prevention of Incisional Hernia After Elective Open Abdominal Aortic Aneurysm (AAA) RepairTerminatedNo Results AvailableAbdominal Aortic AneurysmDevice: Ultrapro® Mesh implantation|Other: Standard wound closurehttps://ClinicalTrials.gov/show/NCT01189708
105131105131Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen FailureCompletedNo Results AvailableHIV|AIDS|Lopinavir|Treatment FailureDrug: Ritonavir-boosted lopinavir|Drug: optimized background regimens (OBRs)https://ClinicalTrials.gov/show/NCT01189695
105132105132Impact of Tegaderm HP and CHG in Major Catheter Related Infections and Dressing DetachmentCompletedNo Results AvailableCatheter-Related InfectionsProcedure: Tegaderm, Tegaderm HP, Tegaderm CHGhttps://ClinicalTrials.gov/show/NCT01189682
105133105133n-3 Polyunsaturated Fatty Acids (PUFA) Supplementation in Young Women With Polycystic Ovary Syndrome (PCOS)CompletedNo Results AvailablePolycystic Ovary SyndromeDietary Supplement: LC n-3 PUFA (fish oil) Supplement|Dietary Supplement: Placebo (olive oil) supplementhttps://ClinicalTrials.gov/show/NCT01189669
105134105134A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis BActive, not recruitingNo Results AvailableChronic Hepatitis B Patients With HBeAg-positiveBiological: HBV DNA Vaccinehttps://ClinicalTrials.gov/show/NCT01189656
105135105135Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell TumorRecruitingNo Results AvailableSarcoma|Desmoplastic Small Round Cell Tumor (DSRCT)Drug: irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylatorhttps://ClinicalTrials.gov/show/NCT01189643
105136105136Medtronic Observational Study in the "Real World" of Implantable Electronic Cardiac DevicesEnrolling by invitationNo Results AvailableHeart Failurehttps://ClinicalTrials.gov/show/NCT01189630
105137105137Safety Study for an All-in-One Body and Personal LubricantCompletedHas ResultsLubricating AgentsDevice: Formula PD-F-7619https://ClinicalTrials.gov/show/NCT01189617
105138105138Dose Rate Range Finding Study of Propofol for minimal-to Moderate Sedation on Upper & Lower Endoscopic TestsCompletedHas ResultsGastrointestinal Endoscopy|Gastrointestinal PolypectomyDrug: Placebo|Drug: ICI35,868 (propofol)|Drug: ICI35,868 (propofol)|Drug: ICI35,868 (propofol)|Drug: ICI35,868 (propofol)|Drug: ICI35,868 (propofol)|Drug: ICI35,868 (propofol)https://ClinicalTrials.gov/show/NCT01189604
105139105139Slow-wave Sleep Deprivation in DepressionCompletedNo Results AvailableMajor Depressive DisorderDevice: Slow-wave deprivationhttps://ClinicalTrials.gov/show/NCT01189591
105140105140Brain Imaging of Cocaine Craving in Recreational Cocaine UsersCompletedNo Results AvailableCocaine Related Disordershttps://ClinicalTrials.gov/show/NCT01189578
105141105141Continuous Postoperative Pulse Oximetry in Patients Presenting for Total Hip and Total Knee ReplacementCompletedNo Results AvailableTotal Knee Replacementhttps://ClinicalTrials.gov/show/NCT01189565
105142105142Depression Treatment for Low Income Substance UsersRecruitingNo Results AvailableMajor Depressive Disorder|Substance UseBehavioral: LETS ACT Behavioral Activation Treatment|Behavioral: Nondirective Therapy (NDT)https://ClinicalTrials.gov/show/NCT01189552
105143105143Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO)RecruitingNo Results AvailableBranch Retinal Vein OcclusionDrug: Ranibizumab|Procedure: macular laser photocoagulationhttps://ClinicalTrials.gov/show/NCT01189526
105144105144SCH-900105 in Recurrent GlioblastomaWithdrawnNo Results AvailableGlioblastomaDrug: SCH 900105https://ClinicalTrials.gov/show/NCT01189513
105145105145Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female SubjectsCompletedHas ResultsPharmacokineticsDrug: Tamoxifen|Drug: Tamoxifen and Desvenlafaxine Succinate Sustained Releasehttps://ClinicalTrials.gov/show/NCT01189500
105146105146The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)CompletedHas ResultsPneumonia, BacterialDrug: ampicillin sodium/sulbactam sodiumhttps://ClinicalTrials.gov/show/NCT01189487
105147105147Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface DiseasesCompletedNo Results AvailableEyelid DiseasesDevice: Blephasteamhttps://ClinicalTrials.gov/show/NCT01189474
105148105148Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular EdemaCompletedHas ResultsAnti- VGF Inhibitor|Diabetic Macular Edema|Diabetic RetinopathyDrug: pegaptanib sodiumhttps://ClinicalTrials.gov/show/NCT01189461
105149105149Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During PregnancyRecruitingNo Results AvailableCongenital ToxoplasmosisDrug: Pyrimethamine/Sulfadiazine|Drug: Spiramycinehttps://ClinicalTrials.gov/show/NCT01189448
105150105150Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or GefitinibTerminatedHas ResultsLung CancerDrug: erlotinibhttps://ClinicalTrials.gov/show/NCT01189435

* Görseller ve İçerik tekif hakkına sahip olabilir